COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTION FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT INHIBITOR, FOR KNEE OSTEOARTHRITIS

被引：1

作者：

Yazici, Y. ^{[1
]}

Tambiah, J. ^{[1
]}

Swearingen, C. ^{[1
]}

Kennedy, S. ^{[1
]}

Strand, V. ^{[2
]}

Cole, B. ^{[3
]}

Hochberg, M. ^{[4
]}

Bannuru, R. ^{[5
]}

McAlindon, T. ^{[5
]}

机构：

[1] Samumed, San Diego, CA USA

[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[3] Rush Univ, Midwest Orthopaed, Chicago, IL 60612 USA

[4] Univ Maryland, Baltimore, MD 21201 USA

[5] Tufts Univ, Med Ctr, Boston, MA 02111 USA

来源：

OSTEOARTHRITIS AND CARTILAGE | 2019年 / 27卷

关键词：

D O I：

10.1016/j.joca.2019.02.605

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

340

引用

页码：S241 / S242

页数：2

共 50 条

[41] A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
Yazici, Y.
McAlindon, T. E.
Gibofsky, A.
Lane, N. E.
Lattermann, C.
Skrepnik, N.
Swearingen, C. J.
Simsek, I.
Ghandehari, H.
DiFrancesco, A.
Gibbs, J.
Tambiah, J. R. S.
Hochberg, M. C.
OSTEOARTHRITIS AND CARTILAGE, 2021, 29 (05) : 654 - 666
[42] OPTIMIZING SUBJECT SELECTION IN KNEE OSTEOARTHRITIS CLINICAL TRIALS BY RADIOGRAPHIC JOINT SPACE WIDTH: POST-HOC CLINICAL RESPONSE ANALYSIS FROM A PHASE 2B TRIAL OF WNT PATHWAY INHIBITOR, SM04690
Kennedy, Sarah
Swearingen, Christopher
Tambiah, Jeyanesh
Conaghan, Philip G.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 144 - 144
[43] OMERACT-OARSI 'STRICT RESPONDERS' ANALYSIS FROM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
Yazici, Y.
Tambiah, J.
Swearingen, C. J.
DiFrancesco, A.
Strand, V.
OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S187 - S187
[44] JOINT SPACE WIDTH INCLUSION CRITERIA CAN REDUCE KNEE OSTEOARTHRITIS TRIAL HETEROGENEITY: POST-HOC DATA FROM A PHASE 2 TRIAL OF WNT PATHWAY INHIBITOR, SM04690
Conaghan, P.
Tambiah, J.
Swearingen, C. J.
Kennedy, S.
Bowes, M.
Brett, A.
Lattermann, C.
OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S274 - S275
[45] TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR
Kennedy, S.
Ghandehari, H.
Swearingen, C.
Tambiah, J.
Hochberg, M.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 81 - 82
[46] Radiographic Outcomes Were Associated with Pain and Function Responses: Post-Hoc Analysis of Results from a Phase 2 Study of a Small Molecule Wnt Pathway Inhibitor, SM04690, for Knee Osteoarthritis Treatment
Yazici, Yusuf
McAlindon, Timothy E.
Gibofsky, Allan
Lane, Nancy E.
Skrepnik, Nebojsa
Armas, Eddie
Swearingen, Christopher J.
DiFrancesco, Anita
Tambiah, Jeymi
Hochberg, Marc
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[47] Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Yazici, Yusuf
McAlindon, Timothy E.
Fleischmann, Roy
Gibofsky, Allan
Lane, Nancy E.
Kivitz, Alan J.
Skrepnik, Nebojsa
Armas, Eddie
Swearingen, Christopher J.
DiFrancesco, Anita
Tambiah, Jeyanesh R. S.
Hood, John
Hochberg, Marc C.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[48] Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 "Pain on Walking" - Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor
Tambiah, Jeyanesh
Kennedy, Sarah
Ghandehari, Heli
Swearingen, Christopher
Hochberg, Marc C.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[49] Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Strand, Vibeke
Swearingen, Christopher J.
Simsek, Ismail
DiFrancesco, Anita
Tambiah, Jeymi
Yazici, Yusuf
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[50] SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY
Yazici, Y.
McAlindon, T. E.
Fleischmann, R. M.
Gibofsky, A.
Lane, N. E.
Kivitz, A. J.
Majumdar, S.
Strand, V.
Swearingen, C. J.
DiFrancesco, A.
Tambiah, J.
Hood, J.
Hochberg, M. C.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 826 - 826

← 1 2 3 4 5 →